Finally, taking for granted the prognostic significance of tumor mutational status, KRAS and BRAF mutations were correlated with TLR9—T1237C, TLR9—T1486C polymorphisms, and TLR9—T1486C, respectively. This evidence concerns the gene BRAF and neoplasm.